The FDA has determined that agency-approved labeling for buprenorphine-containing transmucosal products to treat opioid dependence (BTODs) can be modified to clarify dosage recommendations to broaden access to the drug, it said in a notice.

The FDA is considering requiring companies to test talc-containing cosmetic products to prevent consumer exposure to asbestos, according to a Federal Register notice.

On Dec. 23, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 20, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

The FDA has issued a final rule that seeks to ensure that the implied nutrient content claim "healthy" is consistent with current nutrition science and federal dietary guidance, particularly the Dietary Guidelines for Americans. It revises the requirements for when the term “healthy” can be used as an implied nutrient content claim in the labeling of human food products, the agency said in a Federal Register notice. The rule is effective Feb. 24; the compliance date is Feb. 25, 2028.

On Dec. 18, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

On Dec. 17, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

On Dec. 16, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 13, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The FDA will open the application portal on Jan. 1 for the Voluntary Qualified Importal Program for fiscal year 2026, according to the agency. The voluntary, fee-based program provides importers with expedited review and importation of human and animal foods into the U.S. To participate in VQIP, food importers must meet certain eligibility requirements, including ensuring that the facilities of their foreign suppliers are certified through the FDA’s Accredited Third-Party Certification Program, the agency said.